tetano
Editor, Senior Moderator
J Transl Med
. 2024 Aug 12;22(1):753.
doi: 10.1186/s12967-024-05560-6. Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity
Ke Lin[SUP] #[/SUP][SUP] 1 [/SUP], Jianpeng Cai[SUP] #[/SUP][SUP] 1 [/SUP], Jingxin Guo[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Haocheng Zhang[SUP] #[/SUP][SUP] 1 [/SUP], Gangqiang Sun[SUP] #[/SUP][SUP] 1 [/SUP], Xun Wang[SUP] #[/SUP][SUP] 4 [/SUP], Kun Zhu[SUP] 1 [/SUP], Quanlin Xue[SUP] 1 [/SUP], Feng Zhu[SUP] 5 [/SUP], Pengfei Wang[SUP] 4 [/SUP], Guanmin Yuan[SUP] 1 [/SUP], Yuhan Sun[SUP] 1 [/SUP], Sen Wang[SUP] 6 7 8 [/SUP], Jingwen Ai[SUP] 9 10 11 [/SUP], Wenhong Zhang[SUP] 1 2 3 [/SUP]
Affiliations
Background: Omicron variant impacts populations with its rapid contagiousness, and part of patients suffered from persistent symptoms termed as long COVID. The molecular and immune mechanisms of this currently dominant global variant leading to long COVID remain unclear, due to long COVID heterogeneity across populations.
Methods: We recruited 66 participants in total, 22 out of 66 were healthy control without COVID-19 infection history, and 22 complaining about long COVID symptoms 6 months after first infection of Omicron, referred as long COVID (LC) Group. The left ones were defined as non-long COVID (NLC) Group. We profiled them via plasma neutralizing antibody titer, SARS-CoV-2 viral load, transcriptomic and proteomics screening, and machine learning.
Results: No serum residual SARS-CoV-2 was observed in the participants 6 months post COVID-19 infection. No significant difference in neutralizing antibody titers was found between the long COVID (LC) Group and the non-long COVID (NLC) Group. Transcriptomic and proteomic profiling allow the stratification of long COVID into neutrophil function upregulated (NU-LC) and downregulated types (ND-LC). The NU-LC, identifiable through a refined set of 5 blood gene markers (ABCA13, CEACAM6, CRISP3, CTSG and BPI), displays evidence of relatively higher neutrophil counts and function of degranulation than the ND-LC at 6 months after infection, while recovered at 12 months post COVID-19.
Conclusion: The transcriptomic and proteomic profiling revealed heterogeneity among long COVID patients. We discovered a subgroup of long COVID population characterized by neutrophil activation, which might associate with the development of psychiatric symptoms and indicate a higher inflammatory state. Meanwhile, a cluster of 5 genes was manually curated as the most potent discriminators of NU-LC from long COVID population. This study can serve as a foundational exploration of the heterogeneity in the pathogenesis of long COVID and assist in therapeutic targeting and detailed epidemiological investigation of long COVID.
Keywords: Long COVID; Neutrophil degranulation; Omicron; Proteome; Transcriptome.
. 2024 Aug 12;22(1):753.
doi: 10.1186/s12967-024-05560-6. Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity
Ke Lin[SUP] #[/SUP][SUP] 1 [/SUP], Jianpeng Cai[SUP] #[/SUP][SUP] 1 [/SUP], Jingxin Guo[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Haocheng Zhang[SUP] #[/SUP][SUP] 1 [/SUP], Gangqiang Sun[SUP] #[/SUP][SUP] 1 [/SUP], Xun Wang[SUP] #[/SUP][SUP] 4 [/SUP], Kun Zhu[SUP] 1 [/SUP], Quanlin Xue[SUP] 1 [/SUP], Feng Zhu[SUP] 5 [/SUP], Pengfei Wang[SUP] 4 [/SUP], Guanmin Yuan[SUP] 1 [/SUP], Yuhan Sun[SUP] 1 [/SUP], Sen Wang[SUP] 6 7 8 [/SUP], Jingwen Ai[SUP] 9 10 11 [/SUP], Wenhong Zhang[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 39135185
- PMCID: PMC11318262
- DOI: 10.1186/s12967-024-05560-6
Background: Omicron variant impacts populations with its rapid contagiousness, and part of patients suffered from persistent symptoms termed as long COVID. The molecular and immune mechanisms of this currently dominant global variant leading to long COVID remain unclear, due to long COVID heterogeneity across populations.
Methods: We recruited 66 participants in total, 22 out of 66 were healthy control without COVID-19 infection history, and 22 complaining about long COVID symptoms 6 months after first infection of Omicron, referred as long COVID (LC) Group. The left ones were defined as non-long COVID (NLC) Group. We profiled them via plasma neutralizing antibody titer, SARS-CoV-2 viral load, transcriptomic and proteomics screening, and machine learning.
Results: No serum residual SARS-CoV-2 was observed in the participants 6 months post COVID-19 infection. No significant difference in neutralizing antibody titers was found between the long COVID (LC) Group and the non-long COVID (NLC) Group. Transcriptomic and proteomic profiling allow the stratification of long COVID into neutrophil function upregulated (NU-LC) and downregulated types (ND-LC). The NU-LC, identifiable through a refined set of 5 blood gene markers (ABCA13, CEACAM6, CRISP3, CTSG and BPI), displays evidence of relatively higher neutrophil counts and function of degranulation than the ND-LC at 6 months after infection, while recovered at 12 months post COVID-19.
Conclusion: The transcriptomic and proteomic profiling revealed heterogeneity among long COVID patients. We discovered a subgroup of long COVID population characterized by neutrophil activation, which might associate with the development of psychiatric symptoms and indicate a higher inflammatory state. Meanwhile, a cluster of 5 genes was manually curated as the most potent discriminators of NU-LC from long COVID population. This study can serve as a foundational exploration of the heterogeneity in the pathogenesis of long COVID and assist in therapeutic targeting and detailed epidemiological investigation of long COVID.
Keywords: Long COVID; Neutrophil degranulation; Omicron; Proteome; Transcriptome.